Valerie Malyvanh Jansen

Insider Reports History

Entity
Individual
Location
C/O Elevation Oncology, Inc., 888 Seventh Avenue, 12 Th Floor, New York, NY
Signature
/s/ Rogan Nunn, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Valerie Malyvanh Jansen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Elevation Oncology, Inc. CHIEF MEDICAL OFFICER Restricted Stock Unit 70K $194K $2.77 Feb 15, 2024 Direct
Elevation Oncology, Inc. CHIEF MEDICAL OFFICER Stock Option (Right to Buy) 225K Feb 15, 2024 Direct
Reneo Pharmaceuticals, Inc. Director Stock Option (right to buy) 15.3K Oct 4, 2024 Direct

Insider Reports Filed by Valerie Malyvanh Jansen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OKUR OnKure Therapeutics, Inc. Oct 4, 2024 1 $0 4 Oct 8, 2024 Director
OKUR OnKure Therapeutics, Inc. Oct 4, 2024 0 $0 3 Oct 8, 2024 Director
ELEV Elevation Oncology, Inc. Feb 15, 2024 2 $0 4 Feb 20, 2024 CHIEF MEDICAL OFFICER
ELEV Elevation Oncology, Inc. Feb 15, 2023 1 $0 4 Feb 17, 2023 CHIEF MEDICAL OFFICER
ELEV Elevation Oncology, Inc. Jan 6, 2023 1 $0 4 Jan 10, 2023 CHIEF MEDICAL OFFICER
ELEV Elevation Oncology, Inc. Feb 14, 2022 1 $0 4 Feb 16, 2022 Chief Medical Officer
ELEV Elevation Oncology, Inc. Oct 19, 2021 1 $0 4 Oct 21, 2021 Chief Medical Officer
ELEV Elevation Oncology, Inc. Oct 19, 2021 0 $0 3 Oct 21, 2021 Chief Medical Officer